We are live on ! Find out more
CYTK icon

Cytokinetics
CYTK

137 hedge funds and large institutions have $251M invested in Cytokinetics in 2018 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 52 increasing their positions, 35 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 24 | Existing positions closed: 8

100% more funds holding in top 10

Funds holding in top 10: 1 → 2 (+1)

49% more repeat investments, than reductions

Existing positions increased: 52 | Existing positions reduced: 35

12% more funds holding

Funds holding: 122 → 137 (+15)

1.96% more ownership

Funds ownership: 70.71% → 72.66% (+2%)

34% less capital invested

Capital invested by funds: $380M → $251M (-$129M)

43% less call options, than puts

Call options by funds: $314K | Put options by funds: $555K

Holders
137
Holders Change
+15
Holders Change %
+12.3%
% of All Funds
3.05%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.04%
New
24
Increased
52
Reduced
35
Closed
8
Calls
$314K
Puts
$555K
Net Calls
-$241K
Net Calls Change
-$283K

Top Buyers

1
GPP
Great Point Partners
Connecticut
+$7.29M
2
WA
Wasatch Advisors
Utah
+$4.14M
3
Citadel Advisors
Citadel Advisors
Florida
+$1.62M
4
FI
Fosun International
China
+$1.3M
5
FCMI
Foresite Capital Management IV
California
+$1.28M

Top Sellers

1
BI
BVF Inc
California
-$7.6M
2
Wellington Management Group
Wellington Management Group
Massachusetts
-$7.37M
3
Invesco
Invesco
Georgia
-$1.45M
4
Millennium Management
Millennium Management
New York
-$1.39M
5
MWNA
Marshall Wace North America
New York
-$1.29M
Name Holding Trade Value Shares
Change 		Change in
Stake
FCMI
26
Foresite Capital Management IV
California
$1.11M +$1.28M +175,148 New
Goldman Sachs
27
Goldman Sachs
New York
$1.07M +$80.9K +11,028 +7%
Morgan Stanley
28
Morgan Stanley
New York
$1.06M +$171K +23,310 +16%
Deutsche Bank
29
Deutsche Bank
Germany
$1.01M -$879K -119,809 -43%
RhumbLine Advisers
30
RhumbLine Advisers
Massachusetts
$936K +$177K +24,169 +20%
Jacobs Levy Equity Management
31
Jacobs Levy Equity Management
New Jersey
$924K +$307K +41,800 +40%
Citigroup
32
Citigroup
New York
$834K +$738K +100,664 +321%
PAI
33
Palo Alto Investors
California
$782K – – –
USAA
34
United Services Automobile Association
Texas
$732K -$58.7K -8,005 -6%
Legal & General Group
35
Legal & General Group
United Kingdom
$716K -$2.49K -339 -0.3%
OAM
36
Oxford Asset Management
United Kingdom
$637K +$739K +100,781 New
TCIM
37
TIAA CREF Investment Management
New York
$609K -$4.59K -626 -0.6%
TA
38
Teachers Advisors
New York
$594K – – –
IIM
39
Ironwood Investment Management
Massachusetts
$574K -$75.6K -10,308 -10%
Prudential Financial
40
Prudential Financial
New Jersey
$539K -$8.58K -1,170 -1%
New York State Teachers Retirement System (NYSTRS)
41
New York State Teachers Retirement System (NYSTRS)
New York
$535K +$12.7K +1,725 +2%
ASRS
42
Arizona State Retirement System
Arizona
$532K +$36.7K +5,009 +6%
Ohio Public Employees Retirement System (OPERS)
43
Ohio Public Employees Retirement System (OPERS)
Ohio
$527K +$156K +21,268 +34%
Swiss National Bank
44
Swiss National Bank
Switzerland
$519K -$24.2K -3,300 -4%
PPA
45
Parametric Portfolio Associates
Washington
$519K +$154K +21,024 +34%
UBS Group
46
UBS Group
Switzerland
$517K +$549K +74,860 +1,079%
California State Teachers Retirement System (CalSTRS)
47
California State Teachers Retirement System (CalSTRS)
California
$496K +$56.1K +7,652 +11%
California Public Employees Retirement System
48
California Public Employees Retirement System
California
$478K – – –
Two Sigma Advisers
49
Two Sigma Advisers
New York
$403K -$23.5K -3,200 -5%
Canada Life
50
Canada Life
Manitoba, Canada
$388K – – –
1
2
3 4 5

CYTK Hedge Fund Activity: Q4 2018 in Review

137 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in Cytokinetics (CYTK) for Q4 2018, worth a combined $251M — down 34% from $380M a quarter earlier.

Buyers outnumbered sellers: 24 funds opened new CYTK positions and 8 closed out — a net gain of 16 holders — while 52 added to existing stakes and 35 trimmed.

The largest buyer was Great Point Partners, adding an estimated $7.29M. The largest seller was BVF Inc, cutting an estimated $7.6M.

  • 137 institutional investors held Cytokinetics (CYTK) as of Q4 2018, up from 122 in Q3 2018.
  • Funds reported $251M of Cytokinetics stock for Q4 2018, down 34% quarter-over-quarter.
  • 24 funds opened new Cytokinetics positions in Q4 2018 and 8 closed out, a net change of +16 holders.
  • The largest Cytokinetics buyer in Q4 2018 was Great Point Partners, an estimated $7.29M added.
  • The largest Cytokinetics seller in Q4 2018 was BVF Inc, an estimated $7.6M sold.

Based on aggregated 13F filings for Q4 2018.